John Auchampach

Medical College of Wisconsin, Milwaukee, WI, United States 
Molecular Biology
"John Auchampach"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wan TC, Tampo A, Kwok WM, et al. (2019) Ability of CP-532,903 to protect mouse hearts from ischemia/reperfusion injury is dependent on expression of A adenosine receptors in cardiomyoyctes. Biochemical Pharmacology
Tosh DK, Rao H, Bitant A, et al. (2019) Design and in Vivo Characterization of A Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series. Journal of Medicinal Chemistry
Yu J, Mannes P, Jung YH, et al. (2018) Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A adenosine receptor antagonists. Medchemcomm. 9: 1920-1932
Tosh DK, Ciancetta A, Mannes P, et al. (2018) Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. Acs Omega. 3: 12658-12678
Wodsedalek DJ, Paddock SJ, Wan TC, et al. (2018) IL13 Promotes in vivo Neonatal Cardiomyocyte Cell Cycle Activity and Heart Regeneration. American Journal of Physiology. Heart and Circulatory Physiology
Carlin JL, Jain S, Duroux R, et al. (2018) Activation of adenosine Aor Areceptors causes hypothermia in mice. Neuropharmacology
Duroux R, Ciancetta A, Mannes P, et al. (2017) Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners. Medchemcomm. 8: 1659-1667
Du L, Gao ZG, Paoletta S, et al. (2017) Species differences and mechanism of action of A3 adenosine receptor allosteric modulators. Purinergic Signalling
Tosh DK, Janowsky A, Eshleman AJ, et al. (2017) Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters. Journal of Medicinal Chemistry
Carlin JL, Jain S, Gizewski E, et al. (2016) Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms. Neuropharmacology
See more...